(Q39418067)

11 September 2017

title

Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy (English)

1 reference

progressive multifocal leukoencephalopathy

11 September 2017

main subject

0 references

12

Ralf Gold

1 reference

11 September 2017

6

Ingo Kleiter

1 reference

11 September 2017

4

Kerstin Hellwig

1 reference

11 September 2017

Robert Hoepner

1

1 reference

11 September 2017

Eva M Kolb

2

1 reference

11 September 2017

Stefanie Dahlhaus

3

1 reference

11 September 2017

Ortwin Adams

5

1 reference

11 September 2017

Anke Salmen

7

1 reference

11 September 2017

Ruth Schneider

8

1 reference

11 September 2017

Carsten Lukas

9

1 reference

11 September 2017

Andrew Chan

10

1 reference

11 September 2017

Joseph R Berger

11

1 reference

11 September 2017

publication date

6 September 2016

1 reference

Multiple Sclerosis Journal

11 September 2017

published in

1 reference

11 September 2017

volume

23

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

830-835

1 reference

Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458516667241

New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516667241

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516667241

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516667241

Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516667241

Treatment of progressive multifocal leukoencephalopathy associated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516667241

PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516667241

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516667241

Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516667241

21 January 2018

Identifiers

DOI

10.1177/1352458516667241

1 reference

11 September 2017

1 reference